ArticleBlood advances2024

Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura.

Cecily Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.